Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002004604 | SCV002230260 | uncertain significance | not provided | 2023-04-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1449441). This variant has not been reported in the literature in individuals affected with RIMS1-related conditions. This variant is present in population databases (rs762108313, gnomAD 0.002%). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 675 of the RIMS1 protein (p.Ile675Thr). |
Institute of Human Genetics, |
RCV002286434 | SCV002576474 | uncertain significance | Cone-rod dystrophy 7 | 2022-08-08 | criteria provided, single submitter | clinical testing | Criteria applied: PM1_SUP,PM2_SUP,PP3 |
Ambry Genetics | RCV004043920 | SCV003588343 | uncertain significance | not specified | 2021-11-02 | criteria provided, single submitter | clinical testing | The c.2024T>C (p.I675T) alteration is located in exon 10 (coding exon 10) of the RIMS1 gene. This alteration results from a T to C substitution at nucleotide position 2024, causing the isoleucine (I) at amino acid position 675 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |